Screener
Agios Pharmaceuticals AGIO Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $31.17M.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
FAQ
- What is Agios Pharmaceuticals's total debt?
- Agios Pharmaceuticals (AGIO) reported total debt of $31.17M in Q2 2026.
- How has Agios Pharmaceuticals's total debt changed year-over-year?
- Agios Pharmaceuticals's total debt decreased by 36.1% year-over-year, from $48.76M to $31.17M.
- What is the long-term trend for Agios Pharmaceuticals's total debt?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's total debt has grown at a -17.5% compound annual growth rate (CAGR), from $105.2M to $40.21M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Agios Pharmaceuticals's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude